Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash	$ 64,737	$ 77,258
Accounts receivable	89	200
Prepaid expenses, deposits, and other current assets	6,176	5,179
Total current assets	71,002	82,637
Fixed assets, net	2,066	1,585
Operating lease right-of-use assets	2,951
Intangible assets, net	7,620	2,029
Other assets	695	725
Total assets	84,334	86,976
Current liabilities:
Accounts payable	8,235	3,299
Accrued expenses and other current liabilities	3,498	4,259
Operating lease liabilities, current portion	873
Contingent purchase consideration payable	4,887
Total current liabilities	17,493	7,558
Long-term liabilities
Operating lease liabilities, less current portion	2,108
Total long-term liabilities	2,108
Total liabilities	19,601	7,558
Commitments and contingencies (Note 10)
Stockholders’ Equity:
Preferred stock, $0.001 par value. Authorized, 20,000,000 shares; Series B Convertible Preferred Stock, par value $0.001, issued and outstanding 1,136,210 at March 31, 2022 and 1,113,919 shares at December 31, 2021	2,486	2,419
Common stock, $0.001 par value. Authorized, 150,000,000 shares; 86,911,646 and 86,367,845 shares outstanding as of March 31, 2022 and December 31, 2021, respectively	87	86
Additional paid-in capital	199,719	198,071
Accumulated deficit	(155,849)	(138,910)
Treasury stock	(512)
Total PAVmed Inc. Stockholders’ Equity	45,931	61,666
Noncontrolling interests	18,802	17,752
Total Stockholders’ Equity	64,733	79,418
Total Liabilities and Stockholders’ Equity	$ 84,334	$ 86,976